background

Scientific Publications

Publication Type

Publication Year

63 Results Found.

BMC Cancer Part of Springer Nature

Scientific Publication by OncoStem

March, 2019

Analytical validation of CanAssist-Breast: an immunohistochemistry based prognostic test for hormone receptor positive breast cancer patients

View

Annals of Oncology

Scientific Publication by OncoStem

November, 2018

CanAssist-Breast-an immunohistochemistry based test for risk of recurrence prediction for early stage breast cancer patients: A cost-effective and accurate solution for Asia

View

Scientific Publication by OncoStem

September, 2018

Risk stratification in early-stage estrogen receptor+/HER2-breast cancer patients: Comparative analysis of cost-effective methods

View

Biomakar Insights

Scientific Publication by OncoStem

July, 2018

Development of a Novel Proteomic Risk-Classifier for Prognostication of Patients With Early-Stage Hormone Receptor–Positive Breast Cancer

View

Annals of Oncology

Scientific Publication by OncoStem

September, 2017

Risk of recurrence prediction and optimum treatment planning for early stage breast cancer patients: A cost-effective, accurate and broad based solution for Asia

View

Journal of Molecular Biomarkers & Diagnosis

Scientific Publication by OncoStem

January 2017

Assessment of Ki67 As a Prognostic Marker in Hormone Receptor Positive Breast Cancer: A Retrospective Study on An Indian Cohort

View

South Asian Journal of Cancer

Scientific Publication by Renowned Oncologists Worldwide

31 December, 2021

Purvish Parikh et al: Practical Consensus Recommendations for Optimizing Risk versus Benefit of Chemotherapy in Patients with HR Positive Her2 Negative Early Breast Cancer in India

View